Table 4.
TTP | |||
---|---|---|---|
Variables | HR | 95% CI | P value |
MIPI intermediate vs low | 0.68 | (0.241-1.99) | .5 |
MIPI high vs low | 0.78 | (0.26-2.36) | .7 |
Ki67 ≥30% | 2.27 | (0.92-5.61) | .075 |
PR after ASCT | 4.74 | (1.02-21.9) | .046 |
Alternating MRD after ASCT (vs persistently MRD NEG after ASCT, M6 and M12) | 5.51 | (2.02-15.0) | <.001 |
Persistently MRD POS after ASCT (vs persistently MRD NEG after ASCT, M6 and M12) | 6.93 | (1.74-27.6) | .006 |
M6, 6 months from transplant; M12, 12 months from transplant; MRD NEG, negative minimal residual disease; MRD POS, positive minimal residual disease; PR, partial response.
78 randomized patients, landmark analysis starting from 12 months from transplant.